Description
MLN2480 is an oral pan-Raf inhibitor designed to inhibit cell proliferation and survival. MLN2480 is currently in clinical trials and displays anticancer chemotherapeutic activity.
Product Unit Size | Cost | Quantity | Stock |
---|
MLN2480 is an oral pan-Raf inhibitor designed to inhibit cell proliferation and survival. MLN2480 is currently in clinical trials and displays anticancer chemotherapeutic activity.
Cas No. | 1096708-71-2 |
---|---|
Purity | ≥98% |
Formula | C17H12Cl2F3N7O2S |
Formula Wt. | 506.30 |
IUPAC Name | 2-[(1R)-1-[(6-amino-5-chloropyrimidine-4-carbonyl)amino]ethyl]-N-[5- chloro-4-(trifluoromethyl)pyridin-2-yl]-1,3-thiazole-5-carboxamide |
Solubility | DMSO 100 mg/mL (197.51 mM) Ethanol 100 mg/mL (197.51 mM) Water Insoluble |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet | |
Brochures |
http://clinicaltrials.gov/show/NCT01425008
MELK inhibitor.
ATP-sensitive K+ channel activator, α-adrenerg...
NSAID; COX-1/2 and PDE inhibitor.
EGFR inhibitor.
Induces ER degradation.
Furanocoumarin found in Psoralea coryfolia, DNA...
SERT and NET inhibitor, Nav1.7 Na+ channel bloc...
Mycotoxin produced by Alternaria; topoisomerase...
γ-Secretase inhibitor.
Endogenous peptide hormone inolved in gastric e...
Phenylpyrazoleanilide; IL-17 production inhibit...
Inhibitor of Monoacyglycerol lipase (MAGL).
Thiol derivative, antioxidant.
EGFR (T790M) inhibitor.
Fluoroquinolone; topoisomerase IV and bacterial...
Flavonolignan mixture found in Silybum (milk th...
Steroid; glucocorticoid agonist.
NSAID; COX-2 inhibitor.
Nucleoside antibiotic mixture; GlcNAc phosphotr...
Alkaloid produced by Streptomyces, precursor in...